NSN 6505-01-126-1927 of Chlordiazepoxide Hydrochloride A - Parts Details
| Alternative NSN: 6505011261927 |
| Item Name: Chlordiazepoxide Hydrochloride A |
| FSG: 65 Medical Dental and Veterinary Equipment and Supplies |
| Federal Supply Class (FSC): 6505 Drugs and Biologicals |
| NIIN: 011261927 |
| NCB Code: USA (01) |
| Manufacturers: Major Pharmaceuticals Llc , Baxter Healthcare Ltd , Generics Bidco I Llc , Danbury Pharmacal Inc , Valeant Pharmaceuticals , Hoffmannla Roche Inc |
ASAP Aviation Procurement, owned and operated by ASAP Semiconductor, is the latest parts procurement platform for the aerospace and aviation industry. Check out high demanding part numbers NDC00904-2503-60, NDC00677-1247-01, NDC00603-2714-21, NDC00591-4007-01, NDC00187-4100-10 under NSN 6505-01-126-1927 of Chlordiazepoxide Hydrochloride A manufactured by Major Pharmaceuticals Llc, Baxter Healthcare Ltd, Generics Bidco I Llc, Danbury Pharmacal Inc, Valeant Pharmaceuticals.
Federal Supply Class of NSN 6505-01-126-1927 is FSC 6505 contains part details of Drugs and Biologicals. Quote for your desired part numbers.
Part Number's List for NSN 6505-01-126-1927, 6505011261927
-
Part No Manufacturer Item Name QTY RFQ NDC00904-2503-60 Major Pharmaceuticals Llc chlordiazepoxide hydrochloride a Avl RFQ NDC00677-1247-01 Baxter Healthcare Ltd chlordiazepoxide hydrochloride a Avl RFQ NDC00603-2714-21 Generics Bidco I Llc chlordiazepoxide hydrochloride a Avl RFQ NDC00591-4007-01 Danbury Pharmacal Inc chlordiazepoxide hydrochloride a Avl RFQ NDC00187-4100-10 Valeant Pharmaceuticals chlordiazepoxide hydrochloride a Avl RFQ NDC00140-0007-49 Hoffmannla Roche Inc chlordiazepoxide hydrochloride a Avl RFQ
Characteristics Data of NSN 6505011261927MRC Criteria Characteristic AKJA ACTIVE MEDICAMENT MEDICINAL STRENGTH 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT AKJC CAPSULE TYPE ANY ACCEPTABLE CBBL FEATURES PROVIDED INDIVIDUALLY SEALED CQCT PRIMARY CONTAINER TYPE STRIP CQLS CAPSULE CONTENT FORM ANY ACCEPTABLE CSCW TOTAL PRIMARY CONTAINER QUANTITY 10 CSGS ADMINISTRATION ORAL CXCY III PART NAME ASSIGNED BY CONTROLLING AGENCY LIBRAX CAPSULES 10 STRIPS OF 10 CAPSULES CYLZ CAPSULE PRIMARY CONTAINER CONTENT QUANTITY 10.000 SUPP SUPPLEMENTARY FEATURES MEDSEP ITEM FOR DOD,HOFFMANN-LA ROCHE INC
| MRC | Criteria | Characteristic |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT |
| AKJC | CAPSULE TYPE | ANY ACCEPTABLE |
| CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
| CQCT | PRIMARY CONTAINER TYPE | STRIP |
| CQLS | CAPSULE CONTENT FORM | ANY ACCEPTABLE |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| CSGS | ADMINISTRATION | ORAL |
| CXCY | III PART NAME ASSIGNED BY CONTROLLING AGENCY | LIBRAX CAPSULES 10 STRIPS OF 10 CAPSULES |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 10.000 |
| SUPP | SUPPLEMENTARY FEATURES | MEDSEP ITEM FOR DOD,HOFFMANN-LA ROCHE INC |